Guardant Competitors
GH Stock | USD 16.67 0.28 1.71% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Guardant Health competition on your existing holdings.
Guardant |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardant Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardant Health Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Guardant Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Guardant and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Guardant Health does not affect the price movement of the other competitor.
0.56 | 0.68 | -0.42 | -0.29 | -0.01 | ILMN | ||
0.56 | 0.78 | -0.18 | 0.01 | 0.45 | TWST | ||
0.68 | 0.78 | -0.08 | 0.07 | 0.47 | MYGN | ||
-0.42 | -0.18 | -0.08 | 0.92 | 0.61 | A | ||
-0.29 | 0.01 | 0.07 | 0.92 | 0.7 | TMO | ||
-0.01 | 0.45 | 0.47 | 0.61 | 0.7 | DHR | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Guardant Stock performing well and Guardant Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Guardant Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ILMN | 1.83 | (0.32) | 0.00 | (0.10) | 0.00 | 3.65 | 9.89 | |||
TWST | 2.81 | (0.44) | 0.00 | (0.10) | 0.00 | 6.34 | 18.88 | |||
MYGN | 2.07 | (0.17) | 0.00 | (0.03) | 0.00 | 4.77 | 17.90 | |||
A | 1.18 | (0.01) | 0.00 | 0.03 | 1.41 | 2.26 | 6.31 | |||
TMO | 0.92 | (0.05) | (0.03) | 0.01 | 1.26 | 1.80 | 6.87 | |||
DHR | 0.94 | 0.04 | 0.04 | 0.08 | 1.05 | 2.27 | 7.45 |
Cross Equities Net Income Analysis
Compare Guardant Health and related stocks such as Illumina, Twist Bioscience Corp, and Myriad Genetics Net Income Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ILMN | (5.5 M) | 86.6 M | 151.3 M | 125.3 M | 353.4 M | 461.6 M | 462.6 M | 726 M | 826 M | 1 B | 656 M | 762 M | (4.4 B) | (1.2 B) | (1.1 B) |
TWST | (44.1 M) | (44.1 M) | (44.1 M) | (44.1 M) | (44.1 M) | (44.1 M) | (59.3 M) | (71.2 M) | (107.7 M) | (139.9 M) | (152.1 M) | (217.9 M) | (204.6 M) | (184.2 M) | (193.4 M) |
MYGN | (5.9 M) | 112.2 M | 147.1 M | 176.2 M | 80.2 M | 125.3 M | 21.8 M | 131 M | 4.6 M | 4.6 M | (223.7 M) | (27.2 M) | (112 M) | (128.8 M) | (122.4 M) |
A | 257 M | 1.2 B | 724 M | 497 M | 398 M | 460 M | 684 M | 316 M | 1.1 B | 719 M | 1.2 B | 1.3 B | 1.2 B | 1.4 B | 1.5 B |
TMO | 9.6 M | 1.3 B | 1.2 B | 1.3 B | 1.9 B | 2 B | 2 B | 2.2 B | 2.9 B | 3.7 B | 6.4 B | 7.7 B | 7 B | 6 B | 6.3 B |
DHR | 5.6 M | 2.2 B | 2.4 B | 2.7 B | 2.6 B | 3.4 B | 2.6 B | 2.5 B | 2.7 B | 3 B | 3.6 B | 6.4 B | 7.2 B | 4.7 B | 5 B |
Guardant Health and related stocks such as Illumina, Twist Bioscience Corp, and Myriad Genetics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Guardant Health financial statement analysis. It represents the amount of money remaining after all of Guardant Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Guardant Health Competitive Analysis
The better you understand Guardant Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Guardant Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Guardant Health's competition over several years is one of the best ways to analyze its investment potential.Better Than Average | Worse Than Peers | View Performance Chart |
Guardant Health Competition Performance Charts
Five steps to successful analysis of Guardant Health Competition
Guardant Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Guardant Health in relation to its competition. Guardant Health's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Guardant Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Guardant Health's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Guardant Health, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Guardant Health position
In addition to having Guardant Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Automobiles and Trucks Thematic Idea Now
Automobiles and Trucks
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Automobiles and Trucks theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Automobiles and Trucks Theme or any other thematic opportunities.
View All Next | Launch |
Check out Guardant Health Correlation with its peers. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.